Literature DB >> 20399742

Dynamic association of p300 with the promoter of the G protein-coupled rat delta opioid receptor gene during NGF-induced neuronal differentiation.

Yulong L Chen1, Nancy Monteith, Ping-Y Law, Horace H Loh.   

Abstract

The G protein-coupled delta opioid receptor (DOR) plays a critical role in pain control. Emerging evidence shows that DOR also plays a role in neuronal differentiation and survival. Nerve growth factor (NGF) is known to be critical for the development and maintenance of the central and peripheral nervous systems. Our previous studies have shown that sustained activation of NGF/PI3K/Akt/NF-kappaB signaling is essential for NGF-induced dor gene expression during neuronal differentiation and that the epigenetic modifications at histone 3 lysine 9 temporally correlate with the dor gene transcription. In this study, we cloned the rat dor gene promoter and identified an NGF-responsive region similar to that from the mouse dor gene promoter. We further identified p300, a known NF-kappaB binding partner with intrinsic histone acetyltransferase activity, to be dynamically associated with the dor gene. We also found that assembling of RNA polymerase II (Pol II) at the promoter took place before NGF stimulation, indicating that p300 could only interact with preassembled Pol II at the promoter after NGF stimulation. Taken together, these results implicate that preassembly of the Pol II preinitiation complex, sustained activation of PI3K/Akt/NF-kappaB signaling, and dynamic p300 association at the promoters sequentially is one of the mechanisms of induction of the late phase genes during NGF-induced neuronal differentiation. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399742     DOI: 10.1016/j.bbrc.2010.04.083

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

2.  Mu-opioid signaling modulates biphasic expression of TrkB and IκBα genes and neurite outgrowth in differentiating and differentiated human neuroblastoma cells.

Authors:  Aiyun Wen; Abra Guo; Yulong L Chen
Journal:  Biochem Biophys Res Commun       Date:  2013-02-16       Impact factor: 3.575

3.  A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.

Authors:  Shane V Hegarty; Eimear O'Leary; Franziska Solger; Joanna Stanicka; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Neurotox Res       Date:  2016-06-02       Impact factor: 3.911

4.  Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment.

Authors:  O Levran; E Peles; S Hamon; M Randesi; C Zhao; B Zhang; M Adelson; M J Kreek
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

5.  Crosstalk between delta opioid receptor and nerve growth factor signaling modulates neuroprotection and differentiation in rodent cell models.

Authors:  Dwaipayan Sen; Michael Huchital; Yulong L Chen
Journal:  Int J Mol Sci       Date:  2013-10-21       Impact factor: 5.923

6.  Podoplanin Gene Disruption in Mice Promotes in vivo Neural Progenitor Cells Proliferation, Selectively Impairs Dentate Gyrus Synaptic Depression and Induces Anxiety-Like Behaviors.

Authors:  Ana Cicvaric; Hannah M Sachernegg; Tamara Stojanovic; Dörte Symmank; Tarik Smani; Thomas Moeslinger; Pavel Uhrin; Francisco J Monje
Journal:  Front Cell Neurosci       Date:  2020-01-15       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.